diatrizoate meglumine and diatrizoate sodium · DIATRIZOATE MEGLUMINE 600 mg/mL; DIATRIZOATE SODIUM 100 mg/mL · Solution · Oral; Rectal · Liebel-Flarsheim Company LLC
NDC 00019-4816-04 · 25 BOTTLE, GLASS in 1 BOX / 30 mL in 1 BOTTLE, GLASS · ANDA · View full market →
Just 3 companies supply this market — thin enough that a single exit would be felt immediately. One of its named manufacturing plants, Liebel-Flarsheim Company LLC, failed FDA inspectionwithin the last two years — the agency’s most serious outcome.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Not scored — fragility is computed for NADAC-priced NDCs.
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
No FDA shortage reports for this drug or its presentations.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Camber Pharmaceuticals, Inc. | DIATRIZOATE MEGLUMINE 660 mg/mL; DIATRIZOATE SODIUM 100 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Liebel-Flarsheim Company LLC | DIATRIZOATE MEGLUMINE 600 mg/mL; DIATRIZOATE SODIUM 100 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Guardian Drug Company | DIATRIZOATE MEGLUMINE 660 mg/mL; DIATRIZOATE SODIUM 100 mg/mL | Jul 15, 2026 | Aug 28, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Md Gastroview — NDC 00019-4816-04," retrieved September 3, 2026, https://drugdashboards.com/drug/00019481604.
Free to cite with attribution — see how the data is put together.